Detalles de la búsqueda
1.
Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.
Vaccine
; 28(3): 834-9, 2010 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19857447
2.
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
Vaccine
; 27(33): 4483-9, 2009 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-19486955
3.
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.
Vaccine
; 26(34): 4382-6, 2008 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18599165
4.
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
J Infect Dis
; 198(4): 493-9, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18588481
Resultados
1 -
4
de 4
1
Próxima >
>>